High-content molecular profiling of T-cell therapy in oncology Novosiadly et al. Molecular Therapy — Oncolytics Papers February 2016 Authors and Affiliates Ruslan Novosiadly1 & Michael Kalos1 1Department of Cancer Immunobiology, Eli Lilly and Company, New York, New York, USA
